Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease
Clinical trial NCT07280299 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07280299
- Sponsor
- Gain Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2028-06-30
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.